AAPM 第263任务组:放射肿瘤学名词标准化
A substantial barrier to the single- and multi-institutional aggregation of data to supporting clinical trials, practice quality improvement efforts, and development of big data analytics resource systems is the lack of standardized nomenclatures for expressing dosimetric data.…
要点
- 标准化结构名称、剂量学数据命名及临床试验模板,促进数据汇总。
- 由57名多学科国际成员开发并试点验证命名系统。
- 最终报告经8个AAPM委员会及ASTRO、ESTRO、AAMD审查批准。
核心结论
- 缺乏标准化命名是数据汇总支持临床试验、质量改进和大数据分析的主要障碍,AAPM第263任务组为此制定了命名指南和值。
研究设计与样本
- 由57名代表多学会、多学科、多国家的成员组成工作组,涵盖物理师、医师、剂量师和供应商,开发并试点验证命名系统。
主要发现
- 开发了靶区和危及器官体积及DVH命名系统的命名系统,并在多个诊所和临床试验框架内试点证明可行性。
关键数值与推荐
- 标准化范围包括:图像处理和治疗计划系统平台的结构名称;剂量学数据命名(如基于DVH的指标);临床试验组和软件平台用户的模板;可容纳未来新增结构的命名规则形式化。
临床怎么用
- 建议在临床试验、数据汇总倡议、基于人群的研究和常规临床护理中采用标准化命名,以促进数据汇总和分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A substantial barrier to the single- and multi-institutional aggregation of data to supporting clinical trials, practice quality improvement efforts, and development of big data analytics resource systems is the lack of standardized nomenclatures for expressing dosimetric data. To address this issue, the American Association of Physicists in Medicine (AAPM) Task Group 263 was charged with providing nomenclature guidelines and values in radiation oncology for use in clinical trials, data-pooling initiatives, population-based studies, and routine clinical care by standardizing: (1) structure names across image processing and treatment planning system platforms; (2) nomenclature for dosimetric data (eg, dose-volume histogram [DVH]-based metrics); (3) templates for clinical trial groups and users of an initial subset of software platforms to facilitate adoption of the standards; (4) formalism for nomenclature schema, which can accommodate the addition of other structures defined in the future. A multisociety, multidisciplinary, multinational group of 57 members representing stake holders ranging from large academic centers to community clinics and vendors was assembled, including physicists, physicians, dosimetrists, and vendors. The stakeholder groups represented in the membership included the AAPM, American Society for Radiation Oncology (ASTRO), NRG Oncology, European Society for Radiation Oncology (ESTRO), Radiation Therapy Oncology Group (RTOG), Children's Oncology Group (COG), Integrating Healthcare Enterprise in Radiation Oncology (IHE-RO), and Digital Imaging and Communications in Medicine working group (DICOM WG); A nomenclature system for target and organ at risk volumes and DVH nomenclature was developed and piloted to demonstrate viability across a range of clinics and within the framework of clinical trials. The final report was approved by AAPM in October 2017. The approval process included review by 8 AAPM committees, with additional review by ASTRO, European Society for Radiation Oncology (ESTRO), and American Association of Medical Dosimetrists (AAMD). This Executive Summary of the report highlights the key recommendations for clinical practice, research, and trials.
引用
- Mayo CS, Moran JM, Bosch W, et al. American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2017. PMID: 29485047. doi:10.1016/j.ijrobp.2017.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。